Human Solute carrier family 22 member 5 (SLC22A5) activation kit by CRISPRa

CAT#: GA104502

SLC22A5 CRISPRa kit - CRISPR gene activation of human solute carrier family 22 member 5



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (2)
Rabbit anti-SLC22A5 Polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 2,700.00


SLC22A5 (Myc-DDK-tagged)-Human solute carrier family 22 (organic cation/carnitine transporter), member 5 (SLC22A5)
    • 10 ug

CNY 4,152.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol SLC22A5
Locus ID 6584
Kit Components

GA104502G1, Solute carrier family 22 member 5 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA104502G2, Solute carrier family 22 member 5 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA104502G3, Solute carrier family 22 member 5 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_003060, NM_001308122
Synonyms CDSP; OCTN2
Summary Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...